American Society of Hematology

2020 Schedule and Program for the ASH Meeting on Lymphoma Biology

The following program is preliminary and subject to change.

Keynote Address: Basic Principles of Lymphoma Biology

Chair:
Ralf Küppers, PhD*
University of Duisburg-Essen
Essen, Germany

Speakers:
Riccardo Dalla-Favera, MD
Columbia University
New York, NY
The Making of Diffuse Large B-Cell Lymphoma

Germinal Center Biology

Chair:
Bertrand Nadel, PhD
Centre d'Immunologie de Marseille-Luminy
Marseille, France

Speakers:
Klaus Rajewsky, MD*
Max Delbrück Center of Molecular Medicine
Berlin, Germany
Selection Processes in the Germinal Center

Dinis Pedro Calado, PhD*
The Francis Crick Institute
London, United Kingdom
Differentiation Processes of Germinal Center B Cells

Jagan R. Muppidi, MD, PhD*
National Cancer Institute
Bethesda, MD
Signaling Events in Germinal Center B Cells

Novel Genetic and Epigenetic Mechanisms in Lymphomagenesis

Chair:
Dan A. Landau, MD
Weill Cornell Medical College
New York, NY

Speakers:
Ari Melnick, MD
Weill Cornell Medical College
New York, NY
Precision Epigenetic Therapy for Follicular and Diffuse Large B-Cell Lymphoma

Hans-Guido Wendel, MD*
Memorial Sloan-Kettering Cancer Center
New York, NY
Targetable Gene Mutations in Germinal Center Derived Lymphomas

Jude Fitzgibbon, PhD
Queen Mary University of London
London, United Kingdom
Targeting KMT2D Mutations in Follicular Lymphomas

Dan A. Landau, MD
Weill Cornell Medical College
New York, NY
The Epigenetic Evolution of Cancer Cells

Disrupted Signaling Pathways and Microenvironment in Lymphoma

Chair:
Christian Steidl, MD
British Columbia Cancer Agency
Vancouver, Canada

Speakers:
Margot Thome-Miazza, PhD
University of Lausanne
Lausanne, Switzerland
Novel Insights into the Role of the CBM Complex in Lymphoma

Karin Tarte, PhD*
University of Rennes
Rennes, France
The Microenvironment in Follicular Lymphoma

Margaret A. Shipp, MD
Dana-Farber Cancer Institute
Boston, MA
Deregulated Signaling Pathways in Diffuse Large B-Cell Lymphoma

Martina Seiffert*
German Cancer Research Center
Heidelberg, Germany
The Microenvironment in Chronic Lymphocytic Leukemia

Understanding Mechanisms of Sensitivity and Resistance to Novel Therapies in Lymphoma

Chair:
Ari Melnick, MD
Weill Cornell Medical College
New York, NY

Speakers:
Arash A. Alizadeh, MD, PhD
Stanford University Medical Center
Stanford, CA
Disease Monitoring and Outcome Prediction for B-Cell Lymphomas Using Circulating Tumor DNA

Louis Staudt, MD
National Cancer Institute
Bethesda, MD
Mechanisms of Resistance to Targeted Therapy of Diffuse Large B-Cell Lymphoma

Anas Younes, MD
Memorial Sloan Kettering Cancer Center
New York, NY
New Drugs for B-Cell Lymphomas

Immunotherapies of Lymphomas

Chair:
Margaret A. Shipp, MD
Dana-Farber Cancer Institute
Boston, MA

Speakers:
Stephen M. Ansell, MD, PhD
Mayo Clinic
Rochester, MN
Alternative Checkpoints in Lymphoma

Catherine M. Bollard, MD
Children's National Health System
Washington, DC
Overcoming TGFb in the Tumor Microenvironment with Cell Therapy

Ranjana Advani, MD
Stanford University
Stanford, CA
Targeting CD47 for Lymphoma Therapy

Ronald Levy, MD
Stanford University School of Medicine
Stanford, CA
Immunotherapy of Lymphomas Using Antibody-Based Approaches

Germinal Center-Derived Lymphomas

Chair:
Laura Pasqualucci, MD
Columbia University
New York, NY

Speakers:
Sandrine Roulland, PhD*
French National Institute of Health and Medical Research
Marseille, France
Early Steps in the Development of Follicular Lymphoma

Reiner Siebert, PhD*
University of Ulm
Ulm, Germany
New Insights in the Pathogenesis of Burkitt Lymphoma

Christian Steidl, MD
British Columbia Cancer Agency
Vancouver, Canada
Pathogenic Crossroads in Primary Mediastinal B-Cell Lymphomas and Hodgkin Lymphoma

Chronic Lymphocytic Leukemia and other Small B-Cell Neoplasms

Chair:
Elias Campo, MD, PhD
University of Barcelona
Barcelona, Spain

Speakers:
Davide Rossi, MD, PhD
Oncology Institute of Southern Switzerland
Novara, Switzerland
Genomic Complexity in Splenic Marginal Zone Lymphoma

Catherine J. Wu, MD
Dana-Farber Cancer Institute
Boston, MA
Tumor Dynamics in the Evolution of Chronic Lymphocytic Leukemia

Inaki Martin Subero, PhD*
Institute of Biomedical Research August Pi Sunyer
Barcelona, Spain
Epigenetic Dysregulation in Small B-Cell Lymphoid Neoplasms

Natural Killer/T-cell Lymphomas

Chair:
Wing C. Chan, MD
City of Hope National Medical Center
Duarte, CA

Speakers:
Kojo S. J. Elenitoba-Johnson, MD
University of Pennsylvania
Philadelphia, PA
Signaling Pathways in Peripheral T-Cell Lymphomas

Teresa Palomero, PhD
Columbia University
New York, NY
Role and Mechanisms of VAV1 Translocations in Peripheral T-Cell Lymphoma

Seishi Ogawa, MD, PhD
Kyoto University
Kyoto, Japan
Molecular Genetics of Peripheral T-Cell Lymphomas

Late Breaking Topics - TBD

back to top